Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes

Diabetic Medicine

Volumn 27, Issue 5, 2010, Pages 538-543

  Bouchi, R ^a   Babazono, T ^a   Yoshida, N ^a   Nyumura, I ^a   Toya, K ^a   Hayashi, T ^a   Hanai, K ^a   Tanaka, N ^a   Ishii, A ^a   Iwamoto, Y ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Albuminuria; Diabetes; Estimated glomerular filtration rate; Silent cerebral infarction

Indexed keywords

ADULT; AGED; ALBUMINURIA; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; CEREBRAL INFARCTION; CHRONIC KIDNEY FAILURE; COMPLICATION; DIABETIC NEPHROPATHY; MIDDLE AGED; PATHOPHYSIOLOGY; PREVALENCE; STATISTICAL MODEL; URINE;

ALBUMINOID; CREATININE;

AGED; ALBUMINS; ALBUMINURIA; CEREBRAL INFARCTION; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC;

EID: 77951271132     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.02922.x     Document Type: Article

References (40)

1. Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 : S1 S246.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004 351 : 1296 1305. (Pubitemid 39268908)
3. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K et al. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005 68 : 228 236. (Pubitemid 43181380)
4. So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN et al. Glomerular filtration rate, cardiorenal end points and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006 29 : 2046 2052. (Pubitemid 44871185)
5. Bouchi R, Babazono T, Nyumura I, Toya K, Hayashi T, Ohta M et al. Is a reduced estimated glomerular filtration rate a risk factor for stroke in patients with type 2 diabetes? Hypertens Res 2009 32 : 381 386.
6. Brantsma AH, Bakker SJ, Hillege HL, de Zeeuw D, de Jong PE, Gansevoort RT, PREVEND Study Group. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion. Nephrol Dial Transplant 2008 23 : 3851 3858.
7. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factor of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke 2002 33 : 21 25. (Pubitemid 34052178)
8. Lee SC, Park SJ, Ki HK, Gwon HC, Chung CS, Byun HS et al. Prevalence and risk factors of silent cerebral infarction in apparently normal adults. Hypertension 2000 36 : 73 77.
9. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997 28 : 1932 1939. (Pubitemid 27458998)
10. Naganuma T, Uchida J, Tsuchida K, Takemoto Y, Tatsumi S, Sugimura K et al. Silent cerebral infarction predicts vascular events in hemodialysis patients. Kidney Int 2005 67 : 2434 2439. (Pubitemid 41623407)
11. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent MRI infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003 348 : 1215 1222. (Pubitemid 36359297)
12. Wada M, Nagasawa H, Iseki C, Takahashi Y, Sato H, Arakawa S et al. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008 272 : 36 42. (Pubitemid 350184068)
13. Kobayashi M, Hirawa N, Yatsu K, Kobayashi Y, Yamamoto Y, Saka S et al. Relationship between silent brain infarction and chronic kidney disease. Nephrol Dial Transplant 2009 24 : 201 207.
14. Longstreth WT Jr., Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ, O'Leary D et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002 33 : 2376 2382.
15. Vermeer SE, den Heijer T, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MMB. Incidence and risk factors of silent cerebral infarcts in the population-based Rotterdam Scan study. Stroke 2003 34 : 392 396. (Pubitemid 36206336)
16. Alberti KGMM, Zimmet P, for the WHO consultation. Definition, diagnosis, and classification of diabetes mellitus and its complications, part 2: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 15 : 539 553. (Pubitemid 28319935)
17. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL et al. ACC/AHA 2005 Practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 2006 113 : e436 e465.
18. Sasaki M, Hirai T, Taoka T, Higano S, Wakabayashi C, Matsusue E et al. Discriminating between silent cerebral infarction and deep white matter hyperintensity using combinations of three types of magnetic resonance images: a multicenter observer performance study. Neuroradiology 2008 50 : 753 758.
19. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al., Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009 53 : 982 992.
20. American Diabetes Association. Nephropathy in diabetes. Diabetes Care 2004 322 : 531 536.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
22. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyörälä K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in non-diabetic and non-insulin-dependent diabetic subjects. Stroke 1996 27 : 2033 2039. (Pubitemid 26372576)
23. Collier A, Rumley A, Rumley AG, Paterson JR, Leach JP, Lowe GD et al. Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. Diabetes 1992 41 : 909 913.
24. Paisley KE, Beaman M, Tooke JE, Mohamed-Ali V, Lowe GD, Shore AC. Endothelial dysfunction and inflammation in asymptomatic proteinuria. Kidney Int 2003 63 : 624 633. (Pubitemid 36126808)
25. Sharma K. The link between obesity and albuminuria: adiponectin and podocyte dysfunction. Kidney Int 2009 76 : 145 148.
26. Gruden G, Cavallo-Perin P, Bazzan M, Stella S, Vuolo A, Pagano G. PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 1994 43 : 426 429. (Pubitemid 24064250)
27. Bianchi S, Bigazzi R, Campese VM. Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications. Am J Kidney Dis 1999 34 : 973 995.
28. Shankar A, Klein R, Moss SE, Klein BE, Wong TY. The relationship between albuminuria and hypercholesterolemia. J Nephrol 2004 17 : 658 665. (Pubitemid 40484578)
29. O'Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005 46 : 200 204.
30. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 2009 32 : 115 121.
31. Ikram MA, Vernooij MW, Hofman A, Niessen QJ, van der Lugt A, Breteler MMB. Kidney function is related to cerebral small vessel disease. Stroke 2008 39 : 55 61.
32. Kobayashi S, Ikeda T, Moriya H, Ohtake T, Kumagai H. Asymptomatic cerebral lacunae in patients with chronic kidney disease. Am J Kidney Dis 2004 44 : 35 41. (Pubitemid 38880924)
33. Seliger SL, Longstreth WT Jr., Kats R, Manolio T, Fried LF, Shlipak M et al. Cystatin C and subclinical brain infarction. J Am Soc Nephrol 2005 16 : 3721 3727. (Pubitemid 46211294)
34. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
35. Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke 1998 28 : 1158 1164. (Pubitemid 28228148)
36. Price TR, Manolio TA, Kronmal RA, Kittner SJ, Yue NC, Robbins J et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults: the Cardiovascular Health Study. Stroke 1997 28 : 1158 1164. (Pubitemid 27248888)
37. Longstreth WT Jr., Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol 1998 55 : 1217 1225. (Pubitemid 28427493)
38. Das RR, Seshadri S, Beiser AS, Kelly-Hayes M, Au R, Himali JJ et al. Prevalence and correlates of silent cerebral infarcts in the Framingham Offspring Study. Stroke 2008 39 : 2929 2935.
39. Vermeer SE, Longstreth WT Jr., Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007 6 : 611 619.
40. Babazono T, Takahashi C, Iwamoto Y. Definition of microalbuminuria in first-morning and random spot urine in diabetic patients. Diabetes Care 2004 27 : 1838 1839. (Pubitemid 38857475)